Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
salimetrics/17 Alpha-OHP/17-alpha-ohp/50 μL188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

salimetrics/17 Alpha-OHP/17-alpha-ohp/50 μL

Serum-SalivaCorrelation0.64
Sensitivity3pg/mL
SampleTestVolume50μL
RecommendedCollectionVolume125μL*
SpecialConsiderationsNo
CollectionProtocolDownloadPDF

17Alpha-OHP(17alpha-hydroxyprogesteroneor17α-hydroxyprogesterone)isa steroidhormone producedintheadrenalglandandgonads.(1,2,3) Itissynthesizedfromprogesterone,anditservesprimarilyasaprecursorcompoundthatisconvertedintocortisolintheadrenalgland,orintoandrogenicandestrogenicsteroidhormonesinthegonads.(3,4)17α-OHPisroutinelyusedforthediagnosticassessmentof21-hydroxylasedeficiency,whichislinkedtocongenitaladrenalhyperplasia,impairedaldosteronesynthesis,andfatalsalt-wasting.(5,6,7,8,9) 17α-OHPexhibitsadiurnalrhythmwithhighervaluesinthemorninganddecreasingoverthedaytoanADIrintheevening.(10,11)17α-OHPenterssalivafrombloodviaintracellularmechanisms,andthereisexcellentcorrelationbetweensalivaandserumvalues.(12)​

  1. Pasquali,R.,Patton,L.,Pocognoli,P.,etal.(2007). 17-Hydroxyprogesteroneresponsestogonadotropin-releasinghormonedisclosedistinctphenotypesoffunctionalovarianhyperandrogenismandpolycysticovarysyndrome. JClinEndocrinMetab,92(11),4208-17.
  2. Şahin,Y.,Keleştimur,F.(1997).17-Hydroxyprogesteroneresponsestogonadotrophin-releasinghormoneagoNISTbuserelinandadrenocorticotrophininpolycysticovarysyndrome:InvestigationofadrenalandovariancytochromeP450c17αdysregulation. HumReprod,12(5),910-13.
  3. Strott,C.A.,Yoshimi,T.,Lipsett,M.B.(1969). Plasmaprogesteroneand17-hydroxyprogesteroneinnormalmenandchildrenwithcongenitaladrenalhyperplasia. JClinInvest,48(5),930-39.
  4. Weliky,I.,Engel,L.L.(1962). Metabolismofprogesterone-4-C14andpregnenolone-7α-H3byhumanadrenaltissue. JBiolChem,238(4),1302-7.
  5. Santos,C.M.,Abad,L.R.,Cua,S.C.&Domingo,C.F.(2003).Monitoringcongenitaladrenalhyperplasiausingbloodspot17-hydroxyprogesteroneassay.SoutheastAsianJTropMedPublicHealth,34(Suppl3),174-8.
  6. Sack,J.,Front,H.,Kaiserman,I.,Schreiber,M.(1997).21-hydroxylasedeficiency:ScreeningandincidenceinIsrael.HormRes,48(3),115-9.
  7. New,M.I.,Levine,L.S.(1984).Congenitaladrenalhyperplasia.MonographsonEndocrinology,26,1-88.
  8. VanderKamp,H.J,Wit,J.M.(2004).Neonatalscreeningforcongenitaladrenalhyperplasia.EurJEndocrinol,151(Suppl.3),U71-5.
  9. Hughes,I.A.,Winter,J.S.(1976). Theapplicationofaserum17-OHprogesteroneradioimmunoassaytothediagnosisandmanagementofcongenitaladrenalhyperplasia.JPediatrics,88(5),766-73.
  10. Gröschl,M.,Rauh,M.,Dörr,H.-G.(2003). Circadianrhythmofsalivarycortisol,17α-hydroxyprogesterone,andprogesteroneinhealthychildren. ClinChem,49(10),1688-91.
  11. Goudas,V.T.,Dumesic,D.A.(1997). Polycysticovarysyndrome. EndocrinolMetabClinNorthAm,26(4),893-912.
  12. Vining,R.F.,McGinley,R.A.(1987). Themeasurementofhormonesinsaliva:Possibilitiesandpitfalls. JSterBiochem,27(1-3),81-94.
新闻动态
行业前沿
技术文章
最新产品